prostate tumor tissue
-
not specified
RNA-seq; Microarray; Clinical Sample Validation; Survival Analysis; ROC Analysis
part of a validated 5-circRNA prognostic signature significantly associated with biochemical recurrence (BCR) beyond clinicopathological variables; individually validated as a predictor of BCR-free survival
circTULP4 is a prognostic circRNA in prostate cancer: higher expression associates with improved BCR-free survival in Cox regression, and it contributes to a validated 5-circRNA signature predicting BCR. No mechanistic experiments are reported.
0.5202
The transcriptional landscape and biomarker potential of circular RNAs in prostate cancer.
combined biological and clinical study